BioVaxys Technology Corp.
BVAXF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$1 | -$3 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.031 | -0.046 | -0.041 | -0.125 |
| % Growth | 32.2% | -12.2% | 67.2% | – |
| EPS Diluted | -0.031 | -0.046 | -0.041 | -0.125 |
| Weighted Avg Shares Out | 29 | 29 | 26 | 22 |
| Weighted Avg Shares Out Dil | 29 | 29 | 26 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | $0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |